Anthraquinone as emerging contaminant: technological, toxicological, regulatory and analytical aspects
Alice Teresa Valduga1,2, Itamar Luís Gonçalves3, Bruna Maria Saorin Puton2
1Graduate Program in Ecology, Universidade Regional Integrada do Alto Uruguai e das Missões-Erechim, Avenida Sete de Setembro, Erechim, RS 1621 Brazil.
Abstract:
Anthraquinone (anthracene-9,10-dione) is a multifaceted chemical used in the paper industry, in the production of synthetic dyes, in crop protection against birds and is released from fossil fuels. Additionally, the anthraquinone scaffold, when substituted with sugars and hydroxyl groups is found in plants as metabolites. Because of these multiple applications, it is produced on a large scale worldwide. However, its toxicological aspects have gained interest, due to the low limits in the foods defined by legislation. Worrying levels of anthracene-9,10-dione have been detected in wastewater, atmospheric air, soil, food packaging and more recently, in actual foodstuffs. Recent investigations aiming to identify the anthracene-9,10-dione contamination sources in teas highlighted the packaging, leaves processing, anthracene metabolism, reactions between tea constituents and deposition from the environment. In this context, this review seeks to highlight the uses, sources, biological effects, analytical and regulatory aspects of anthracene-9,10-dione.
More Related Videos
09:23Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
14:53In Situ Detection and Single Cell Quantification of Metal Oxide Nanoparticles Using Nuclear Microprobe Analysis
Published on: February 3, 2018
Related Concept Videos
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
